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Abstract: Previous studies have shown positive effects of long‐term resveratrol (RSV) supplementation in preventing
pancreatic beta cell dysfunction, arterial stiffening and metabolic decline induced by high‐fat/high‐sugar (HFS) diet in
nonhuman primates. Here, the analysis was extended to examine whether RSV may reduce dietary stress toxicity in the
cerebral cortex of the same cohort of treated animals. Middle‐aged male rhesus monkeys were fed for 2 years with HFS
alone or combined with RSV, after which whole‐genome microarray analysis of cerebral cortex tissue was carried out along
with ELISA, immunofluorescence, and biochemical analyses to examine markers of vascular health and inflammation in the
cerebral cortices. A number of genes and pathways that were differentially modulated in these dietary interventions
indicated an exacerbation of neuroinflammation (e.g., oxidative stress markers, apoptosis, NF‐κB activation) in HFS‐fed
animals and protection by RSV treatment. The decreased expression of mitochondrial aldehyde dehydrogenase 2,
dysregulation in endothelial nitric oxide synthase, and reduced capillary density induced by HFS stress were rescued by
RSV supplementation. Our results suggest that long‐term RSV treatment confers neuroprotection against cerebral vascular
dysfunction during nutrient stress.
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INTRODUCTION

protection against neuroinflammation and help protect
against cognitive decline [22]. The prefrontal cortex is
the critical brain site for decision-making and other
essential components of executive function [23] and
middle-aged individuals with childhood-onset type 1
diabetes display poorer cognitive function [24].
Moreover, peripheral glucose dysregulation that
commonly occurs with obesity is also associated with
high rates of cognitive impairment [25-29]. Because of
the inherent limitation of performing biochemical and
histochemical analyses on post-mortem brain tissue
from patients, the objective of this study was to set out a
research protocol to compare various parameters of
cerebral neuroinflammation in middle-aged male rhesus
monkeys fed a high-fat, high-sucrose (HFS) diet
without and with RSV supplementation for 2 years.
Using this experimental model, we recently reported
that RSV prevents pancreatic β-cells dedifferentiation
[30], promotes metabolic and inflammatory adaptations
in visceral white adipose tissue [31], and reduces the
HFS-induced inflammation and stiffening of the central
arterial wall [32]. In the present study, the prefrontal
cortices on the same cohort of treated animals were
used to test the hypothesis that RSV supplementation
may prevent impairment in cerebral vasculature and
confer neuroprotection through inhibition of oxidative
and inflammatory pathways.

Worldwide incidence of obesity is at an all-time high,
with more than 1.1 billion adults being classified as
overweight or obese. The rise in obesity rates has a
growing impact on the incidence of metabolic
syndrome, cardiovascular disease, type-2 diabetes and
cancer, and the cost of caring for obesity-related
pathologies remains a huge economic burden, with
$147-210 billion going towards the care of patients each
year [1]. Epidemiological studies have shown a
consistent link between increased body mass index at
mid to late life and a stronger risk of late-onset
dementia [2]. High-fat diet has been associated with
central inflammation, brain insulin resistance, and
cognitive decline leading to progressive neurodegeneration [3], and resveratrol (RSV; 3, 4’, 5trihydroxy-trans-stilbene)
supplementation
can
attenuate central inflammation and improve memory
deficits in HFD-fed mice [4].
RSV is a naturally occurring polyphenol compound that
is found in a variety of foods including, but not limited
to, wines, grape juice, nuts, and berries. Since 1940,
RSV has generated considerable interest in the scientific
community due to its ability to protect against a variety
of diseases, including type-2 diabetes, cardiovascular
disease, and cancers [5]. In addition, RSV has been
recently proposed to play a critical role in the reduction
of neuroinflammation caused by cytokines [6] and
preservation of the cerebromicrovasculature density in
cerebral endothelial cells [7, 8]. Obesity has been
associated with marked increase in 4-hydroxynonenal
(4-HNE), a membrane lipid peroxidation byproduct that
induces mitochondrial oxidative stress leading to
neuroinflammation and progressive neurodegeneration
[9, 10]. RSV confers antioxidant protection by reducing
formation of reactive oxygen species and counteracting
the cytotoxic effects of 4-HNE in PC12 cells in vitro
[11]. Additionally, RSV improves endothelial function
and cerebral vascular density [12, 13] by increasing
levels of vascular endothelial growth factor (VEGF)
[14], which enhances angiogenesis [15] and attenuates
ischemic brain damage [16].

RESULTS
Assessment of resveratrol accumulation in monkey
cerebrospinal fluid
Adult male rhesus monkeys (average age at baseline
10.5 ± 0.4 years) were fed a SD, HFS or HFS
supplemented with RSV (HFS+R) diet for 24 months.
Following euthanasia, RSV was detected in CSF of
rhesus monkey on HFS+R diet, but not in SD- or HFSfed animals (Fig. 1). No attempts were made to identify
metabolites of RSV; however, we previously reported
the detection of RSV and resveratrol-3-O-sulfate in the
serum of HFS+R-fed animals, but not of resveratrol-4’O-glucuronide nor 3-O-glucuronide, which were below
the minimum quantitation limits [30]. There are no data
available about concentrations of RSV in CSF in year 1.

Some clinical trials have been conducted to date to
assess the role of RSV supplementation in brain
function and/or neuroinflammation [17-20]. RSV
dietary supplementation lowers infection-related
neuroinflammation and impairment in working memory
in mice [21] while it significantly increases cerebral
blood flow and improves memory function in patients
with an off-balance metabolism (reviewed in ref. [5]).
More recently, it has been suggested that polyphenols
are important to consume in old age as they may offer
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Resveratrol supplementation alters gene expression
profiles in cerebral cortex of HFS-fed monkeys
Whole genome microarray analysis was performed on
cerebral cortex tissues of middle-aged male rhesus
monkeys fed for two years either with SD, HFS or
HFS+R diet. Principal component analysis (PCA)
demonstrated a clear separation of the three
experimental groups (Fig. 2A). The dissimilarity in the
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pattern of gene expression between the HFS_SD and
HFS+R_HFS pairwise comparisons is graphically
represented as heat maps (Fig. 2B), and indicates that
RSV supplementation provides a transcriptional profile
distinct from that elicited by HFS diet alone. Gene
ontology analyses of biological processes highlighted
56 out of a total of 143 GO terms that were shared
between HFS_SD and HFS+R_HFS pairwise
comparisons (Fig. 2C). Of these, there were 55 GO
terms (55/56) enriched by genes that were differentially
expressed between HFS and HFS+R diets, with
“Regulation of transcription DNA dependent”, “Zinc
ion binding” and “Ubiquitin cycle” among the top
expressed GO terms (Fig. 2D). Significantly regulated
genes were then organized into functional pathways
using parametric analysis of gene-set enrichment
(PAGE) analysis. Of the 84 genesets modified between
the two pairwise comparisons, 18 were shared and
populated by genes that were differentially expressed by
HFS and HFS+R (Fig. 2E). “Alzheimers_Disease_
Down”, “Diab_Neph_Down” and “Ageing_Brain_Up”
were among the pathways that were significantly
downregulated by HFS and markedly reversed with
RSV supplementation (Fig. 2F). Among the 3461 genes
whose expression was significantly modified under
these experimental conditions, 14.1% of the transcripts
(488/3461) were shared in response to HFS and
HFS+R, of which 218 genes (corresponding to 44.7% of
the shared transcripts) moved in the same direction by
both interventions (39 and 179 genes up- and downregulated, respectively), while 270 genes (55.3% of the
shared transcripts) were reciprocally altered by HFS and
HFS+R (Fig. 2G). Fig. 2H depicts graphically the
enrichment of these reciprocally regulated genes
associated with the HFS_SD and HFS+R_HFS pairwise
comparisons. The gene encoding the metallothionein
MT1H transcript, which is inducible by ROS-mediated
generation of lipid peroxides [33], was the most
upregulated in response to HFS compared to SD, with a
Z-ratio of +10.53 (Fig. 2H). Other genes upregulated by
HFS included KCNS1 and KCNK12, two voltage-gated
potassium channel modulatory subunits present in the
brain [34, 35]. This finding is consistent with recent
evidence showing that inflammation can alter
expression of neuronal potassium channel subunit
mRNAs [36]. BBOX1 was the most downregulated
transcript in response to HFS, with a Z-ratio of -4.67,
Figure 1. Accumulation of RSV in monkey CSF. At the
time of sacrifice, CSF from SD, HFS and HFS+R animals was
collected and the amount of unconjugated RSV measured by
MS/MS analysis. Upper panel, a CSF sample from SD control
was spiked with 2.5 ng/ml RSV. The detection of RSV is
indicated by *.
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and represented one of many genes that exhibited a
reciprocal pattern of expression with RSV treatment (Fig.
2H). The BBOX1 gene encodes gamma butyrobetaine
hydroxylase, an enzyme implicated in the L-carnitine
biosynthetic pathway in the brain [37]. Interestingly, the

maturation of BBOX1 mRNA is nutritionally regulated to
adjust L-carnitine biosynthesis to the energy supply [38].
The raw data file and the filtered, normalized results are
available online in the Gene Expression Omnibus,
accession number GSE70255.

Figure 2. Resveratrol supplementation elicits differential gene expression profiles in the frontal cerebral cortex of HFS‐fed rhesus
monkeys. (A) Visualization of the principal component analysis (PCA) performed on gene expression data sets from the brain of rhesus
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monkeys maintained on standard diet (SD), high‐fat, high‐sugar diet (HFS) and HFS supplemented with resveratrol for 2 years (HFS+R). (B)
Heat maps representing gene expression profile comparing genes significantly up (red) and downregulated (blue) in HFS vs. SD‐fed
controls and HFS+R vs. HFS. (C) Venn diagram illustrating the number of significantly up and down regulated GO terms observed in
neocortex from HFS vs. SD (blue symbols) and HFS+R vs. HFS‐fed monkeys (red symbols). (D) Enrichment of the 56 shared GO terms
visualized using a two‐dimensional graphical representation of HFS vs. SD (blue bars) and HFS+R vs. HFS (red bars). A list of three shared
GOTerms differentially expressed between the two pairwise comparisons is provided. (E) Venn diagram illustrating the number of
significantly up and down regulated pathways between the two pairwise comparisons. (F) Enrichment of the 18 shared pathways
visualized using a two‐dimensional graphical representation of HFS vs. SD (blue bars) and HFS+R vs. HFS (red bars). A list of three shared
pathways differentially expressed between the two pairwise comparisons is provided. (G) Venn diagram illustrating the number of
significantly up and down regulated genes between the two pairwise comparisons. (H) Enrichment of the 270 shared genes visualized
using a two‐dimensional graphical representation of HFS vs. SD (blue bars) and HFS+R vs. HFS (red bars). A list of six shared genes
differentially expressed between the two pairwise comparisons is provided. (I) 5170 genes from the filtered brain dataset (HFS:HFS+R
comparison) were ranked according to their differential expression and given as input to GOrilla. The resulting enriched GO terms were
visualized using a two‐dimensional graphical representation with color coding reflecting their degree of enrichment/depletion (blue being
the strongest). Additional comparisons (HFS vs. SD) on the same filtered dataset highlight the enrichment of relevant GO terms, such as
“Synapse part”, “Axon part”, “Oxidation‐reduction process” and “Response to axon injury”. (J) mRNA expression analysis in brain cortex
by quantitative RT‐PCR. Relative expression values were normalized to those of SD‐fed control monkeys and represented as scatter plots.
Although the fold changes in GRIN2B, SPTBN1 and KCNB1 expression were small [less than a 2‐fold change], these were in good
agreement with the quantitative RT‐PCR data. SD (n=4); HFS (n=10); HFS+R (n=10). *, **, p <0.05 and 0.01, respectively.

Semantic indexing heatmap analysis [39, 40] of the
monkey cortical brain microarray dataset identified
enriched GO terms that were implicitly involved in
inter-related functional networks associated with
synaptic transmission, axon injury and oxidationreduction processes, when comparing HFS to HFS+R
cohorts (Fig. 2I). Several genes whose transcripts have
been associated with cortical development and neuronal
transmission were impacted by RSV supplementation in
HFS-fed monkeys, and included CHRNA5, GRIN2B and
KCNB1 [41-43]. Expression of a vital component in
actin-cytoskeleton organization in axon, SPTBN1 [44],
was also affected in the HFS+R cohort. Of significance,
HFS diet caused an increase in the expression of CST3,
a transcript that correlates positively with cognitive
impairment in the elderly [45], which did not occur with
RSV supplementation. The expression of GRIN2B,
SPTBN1 and KCNB1 transcripts relevant to CNS was
verified by quantitative RT-PCR analysis (Fig. 2J). The
validated genes belong to the following two GO classes:
“Synapse part (GO:0044456)” – GRIN2B (glutamate
receptor, ionotropic, n-methyl d-aspartate 2b) and
KCNB1 (potassium voltage-gated channel, shab-related
subfamily, member 1), and “Axon part (GO:0033267)”
– SPTBN1 (spectrin, beta, non-erythrocytic 1).

Resveratrol supplementation improves regional
brain capillary density in cerebral cortex of HFS-fed
monkeys

Expression of GRIN2B and SPTBN1 mRNA levels was
significantly lower in HFS+R vs. SD and HFS groups,
while the reduction in KCNB1 mRNA did not quite
reach conventional levels of statistical significance (p=
0.053). Nevertheless, the changes in the mRNA
transcript levels between the microarray and
quantitative RT-PCR data were identical in terms of
direction and magnitude of changes (Fig. 2J).

Cerebral blood flow requires the generation of nitric
oxide and eNOS-derived nitric oxide appears to exhibit
neuroprotection under physiological conditions (review,
see Ref. [46]). Some stimuli trigger the production of
superoxide instead of nitric oxide through increased
monomerization of eNOS and alteration in its
enzymatic function. This phenomenon, termed eNOS
uncoupling, exacerbates oxidative stress and the deple-
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Microscopic visualization was performed to determine
the effect of diets on cerebral vasculature in rhesus
monkeys. A consistent pattern of distribution was
observed in the vascularization of the neocortex of SDfed animals and, by comparison, was substantially less
in HFS brain (Fig. 3A). RSV supplementation offered
significant protection against the HFS-mediated loss in
capillary density in the neocortex. We then investigated
the expression of a series of proteins implicated in
angiogenesis, including von Hippel-Lindau protein
(pVHL), VEGF and endothelial nitric oxide synthase
(eNOS) using Western blot analysis. VHL encodes the
ubiquitin ligase pVHL, and HFS diet caused a
significant increase in pVHL levels with concomitant
reduction in the amount of VEGF protein (Fig. 3, B and
C), which could explain the lower vascularization in the
neocortex of HFS-fed rhesus monkeys (Fig. 3A). A
trend toward reduced accumulation of pVHL without
upregulation of VEGF was observed in HFS+R
compared to HFS cerebral cortex extracts (Fig. 3, B and
C).
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Figure 3. Resveratrol treatment improves capillary density in the cerebral cortex of HFS‐fed rhesus monkeys. (A)
Representative images of cerebral cortical brain capillary staining, and their respective quantification. (B) Solubilized cerebral cortex
extracts from SD‐, HFS‐ and HFS+R‐fed animals were resolved by SDS‐PAGE under reducing conditions, electrotransferred onto
nitrocellulose membranes and subjected to immunoblotting using the indicated primary antibodies. Representative signals associated
with bands of interest are shown, including that of b‐actin, which was used as loading control. All 24 brain samples were ran on a single
gel (Fig. S1). Nitrocellulose membrane staining was also carried out with Ponceau S dye for protein detection. (C) Signals associated
with VEGF and VHL proteins were normalized and represented as box plots. (D) Signals associated with eNOS and FOXO3 proteins were
normalized and represented as box plots. (E) Scatterplot exploring the significant association between eNOS and FOXO3 protein
expression with HFS feeding. (F) SDS‐PAGE was performed at 4oC to enable the separation of eNOS dimers and monomers. Immunoblot
analysis was performed using anti‐eNOS antibody. (G) Ratios of dimeric and monomeric eNOS species were calculated and represented
as box plots. (H) Measurement of H2S levels in monkey brain homogenates. SD (n=4); HFS (n=10); HFS+R (n=10). *, p < 0.05.
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tion of nitric oxide, together with neuronal apoptosis
and ROS release after brain injury [47]. We therefore
examined whether the abundance and/or monomerdimer equilibrium of eNOS would be impacted by
dietary stress. There was a significant increase in the
amount of eNOS protein with a trend toward higher
expression of its transcriptional activator FOXO3 in
response to HFS as compared to SD-fed controls (Fig.
3, B and D). A positive linear relationship between
eNOS levels and FOXO3 expression was established in
the HFS cohort (p < 0004; Fig. 3E), and this correlated
well with a deficit in brain capillary density. Diet
supplementation with RSV significantly reversed the
HFS-mediated increase in the steady-state levels of
FOXO3 and eNOS proteins (Fig. 3, B and D). Despite
the fact that eNOS expression was actually increased by
HFS, the eNOS dimer/monomer ratio was comparable
to that of SD-fed controls while RSV treatment caused a
significant elevation in the ratio (p<0.001, Fig. 3, F and
G). Because the dimeric eNOS is the only form of the
enzyme that produces nitric oxide [48], these results are
consistent with improved cerebral blood flow in the
presence of increased capillary density due to RSV
supplementation.

promotion of the ubiquitination and degradation of NFκB subunits [50]. Further analysis of the microarray
dataset revealed a significant increase in COMMD10
and COMMD3 transcripts with a concomitant reduction
of transcripts corresponding to known NF-κB targets,
such as NFKBIA, TNFRSF25 and IL18, in the cerebral
cortex of HFS+R versus HFS-fed animals (Fig. 4E).
The BCL2 family of genes is transcriptionally regulated
by NF−κB in the brain [51], and we demonstrated here
that diet supplementation with RSV significantly
increased the expression of the antiapoptotic protein
BCL2 with marked reduction in the active (cleaved)
form of caspase 3 as compared to HFS (Fig. 4, F and
G). Low caspase 3 cleavage was also observed in the
HFS group as compared to SD.
Various members of the sirtuin class of NAD(+)dependent, protein deacetylase family have been found to
be involved in processes related to the regulation of
inflammation and neurobiology. Whilst SIRT1 has been
by far the most extensively studied sirtuin, there has been
recent interest in cytoplasmic SIRT2, particularly due to
its abundance in the CNS and its expression increasing
with age [52]. SIRT2 plays an important role for
neurocognitive ability in adult, middle-aged mice and
few studies have demonstrated that inhibition of SIRT2
reduces the aggregation of α-synuclein via modulation of
tubulin activity to mitigate Parkinson’s toxicity [53, 54].
Because high-fat diet is a known inducer of NF-κBmediated neuroinflammation in cerebral cortex [55], we
examined whether RSV contributes to the regulation of
cerebral expression of SIRT2 and its activity as a bona
fide α-tubulin deacetylase [56] in response to HFS.
Immunoblotting revealed significant reduction in SIRT2
protein levels caused by RSV supplementation (Fig. 4H
and I upper panel, Supplemental Fig. 1). The decrease in
SIRT2 levels was accompanied by higher expression of
α-tubulin, which, in turn, led to a significant reduction in
the acetylated/total tubulin ratio in the HFS+R cohort
compared to the HFS group (Fig. 4H and I lower panel,
Supplemental Fig. 1).

The endogenous level of hydrogen sulfide (H2S) dilates
cerebral vessels by activating smooth muscle cell plasma
membrane ATP-sensitive K+ channels. It also increases
eNOS activity by promoting the formation of eNOS
dimers [49]. Here, large intra-individual variations in
H2S levels in SD, HFS and HFS+R groups were
observed (Fig. 3H), making it impossible to determine
whether the RSV-mediated protection in cerebral
vasculature of HFS-fed rhesus monkeys stemmed from
increases in H2S tissue concentration in the brain.
Resveratrol supplementation and inflammatory state
in the cerebral cortex of HFS-fed monkeys
There was no significant difference in the number of
cells positive for the microglial marker Iba1+ among the
groups (Fig. 4A). Despite the low sample size in the SD
group, evidence was provided for higher levels of IL-6
in CSF after HFS feeding (p = 0.0424, Fig. 4B) and for
the lack of difference between the HFS and HFS+R
groups. Additionally, the increased ratio of phosphoactive to total form of NF-κB p65Rel in response to
HFS vs. SD was not conclusive (Fig. 4, C and D), and
neither was the difference in the activation state of
p65Rel between the HFS+R group and HFS (p = 0.057,
Fig. 4, A and D).

Mitochondrial aldehyde dehydrogenase (ALDH2) is
implicated in the metabolism and inactivation of
reactive aldehydes, which represent major end products
of lipid peroxidation and contributing factors in dietinduced neuronal oxidative stress. An association has
been reported between brain ALDH2 levels and
protection against ischemic stroke [57]. Moreover, mice
lacking ALDH2 exhibit endothelial dysfunction, agerelated cognitive impairment and Alzheimer’s disease
[58]. We therefore measured the abundance of ALDH2
protein in the cerebral cortex of HFS-fed rhesus
monkeys and found a significant reduction in its
expression level (Fig. 4J and K, Supplemental Fig. 1).

A critical mechanism of transcriptional suppression of
NF-κB involves the copper metabolism MURR1
domain containing (COMMD) proteins through
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RSV supplementation helped preserve the amount of
ALDH2 despite HFS-mediated oxidative stress, which
may indicate substantial protection against neocortex
damage. Consistent with this, a positive linear
relationship between ALDH2 levels and expression of

the anti-apoptotic BCL2 protein was established in the
HFS+R cohort (Fig. 4L). Taken together, the results
indicate that RSV supplementation may overcome HFSinduced cerebrovascular dysfunction and neuroinflammation by preventing the destabilization of ALDH2.

Figure 4. Effects of resveratrol on neuroinflammation in the cerebral cortex of HFS‐fed rhesus monkeys. (A) Representative
images of Iba1‐positive cells in cerebral cortical brain sections (original magnification: 40x), and their respective quantification.
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(B) IL‐6 levels in CSF. (C‐K) Solubilized cerebral cortex extracts from SD‐, HFS‐ and HFS+R‐fed animals were resolved by SDS‐PAGE under
reducing conditions, electrotransferred onto nitrocellulose membranes and subjected to immunoblotting. All 24 brain samples were ran
on a single gel (Fig. S1). (C) Representative signals associated with phosphorylated and total forms of p65Rel and that of GAPDH, which
was used as loading control. (D) The ratios of phosphorylated/total p65Rel proteins are represented as scatter plots. (E) Enrichment of a
select group of transcripts implicated in NF‐κB signaling both in HFS vs. SD and HFS+R vs. HFS pairwise comparisons. (F) Representative
signals associated with BCL2 and cleaved caspase 3, and that of GAPDH, which was used as loading control. (G) Signals associated with
BCL2 and cleaved caspase 3 proteins were normalized and represented as box plots. (H) Representative immunoblot analysis for SIRT2,
acetylated tubulin, and total tubulin levels. (I) Signals associated with bands of interest were normalized to Ponceau S staining and
represented as box plots. (J) Representative signals associated with ALDH2 and GAPDH, the latter being used as loading control.
Membrane staining was also carried out with Ponceau S dye for protein detection. The migration of molecular‐mass markers (values in
kilodaltons) is shown on the left of the stained membrane. (K) Signal associated with ALDH2 was normalized to GAPDH and represented
as box plots. (L) Scatterplot exploring the significant association between ALDH2 and BCL2 protein expression with HFS+R feeding. SD
(n=4); HFS (n=10); HFS+R (n=10). *, p < 0.05.

DISCUSSION

of eNOS through homodimeric uncoupling provided a
mechanism for diet-induced brain insult. Importantly,
eNOS dimer stabilization was observed in the cerebral
cortex of the HFS+R group vs HFS, and RSV
supplementation was found to attenuate HFS-mediated
induction of eNOS protein and its transcriptional
activator FOXO3. The higher levels of eNOS in the
HFS group may be an attempt in trying to improve
blood flow in the presence of low capillary density due
to HFS. Notable are the studies in which H2S was
reported to affect eNOS function while playing a
cardinal role in the protection of neurons from
secondary injury by functioning as an anti-oxidant and
anti-inflammatory mediator (reviewed in Ref. [61]). We
could not demonstrate the contribution of H2S in
modulating eNOS dimer/monomer ratio and/or activity
due to large intra-individual variations among the
groups. Similar to the protective effects of RSV in the
monkey central arterial wall [32], RSV may potentially
reduce the HFS-induced cerebrovascular inflammation
by limiting transport of circulating cytokines across the
blood-brain barrier, lending credence to the report of
Chang et al. [62], who showed that high-fat diet
supplementation with RSV for 8 weeks significantly
reduced the disruption of the blood-brain barrier while
protecting brain neurons in the mice from apoptotic
insults. Based upon these results, it would have been
interesting to perform a long-term dietary stress first
and then initiate RSV supplementation in order to
restore the cortical brain capillary density and protect
against neuronal brain insults.

The ability of RSV supplementation to promote a shift
away from diet-induced brain inflammation towards
increase in neuronal health in a nonhuman primate
model of obesity highlights important implications for
future translational studies aimed at the prevention of
neuronal damage and brain dysfunction. The fact that
RSV can exert neuroprotective effect in various animal
models under high-caloric conditions is already
established; however, our observations in Rhesus
monkeys represent an unique opportunity to validate
these emerging concepts and for a period far longer than
any clinical trials to date.
Our study on the long-term effect of RSV
supplementation in metabolically impaired monkeys
was initiated several years ago and has led to a number
of significant observations including the decline in
arterial wall stiffening and inflammation [32], lower
pancreatic islet β-cell dedifferentiation [30] and
improved insulin signaling in adipose tissue [31]. Here,
we show that the CSF levels of IL-6 were significantly
higher in HFS monkeys than in the SD group together
with reduction in brain capillary density and amount of
ALDH2 in the cerebral cortex. The gene profiling in the
cerebral cortex of the HFS group resembled that
previously described for physical trauma brain injury
(TBI) in mice [59], with the most striking changes
involving the regulation of functional pathways, notably
“StemCell Embryonic Up”, “StemCell Neural Up”,
“Alzheimer’s Disease Up” and “Alzheimer’s Disease
Dn”. RSV was readily detected in CSF samples from
the HFS+R group, along with the recovery of brain
capillary density and protection against HFS-induced
alteration in NF-κB transcriptional activity.

Administration of RSV has been found to greatly
attenuate global cerebral ischemia by reducing levels of
pro-inflammatory cytokines and promoting a reduction
in associated plaque formation in the rat brain [63]. In
addition, the ability of RSV to acutely inhibit microglial
activation is consistent with its anti-inflammatory
activity against various neurological disorders in
experimental mouse models [64] and in a mouse model
of physical TBI [65]. Here, RSV consumption had only

HFS is associated with alterations in cerebral
vasculature, and consumption of RSV ameliorates
endothelial hyperpermeability in HFS-fed rats partly via
eNOS regulation [60]. We showed that the dysfunction
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minimal impact on both the activation of
macrophage/microglial cell population and the steady
state levels of active NF-κB p65 subunit when
compared to the HFS group. In contrast, there was
significant difference in the expression of genes
involved in the inflammatory process between the HFS
and HFS+R groups, with the RSV-treated group
exhibiting
anti-inflammatory
protection.
The
deacetylase SIRT1 is a putative target of RSV action,
and significant increase in Commd expression has been
reported in the muscle of mice treated with the small
SIRT1 activator, SRT2104, which was accompanied by
SIRT1-mediated inhibition in NF-κB transcriptional
activity [66]. Our results indicated that the SIRT1
content in the monkey cerebral cortex was comparable
among the three experimental groups (data not shown),
although acetylation levels of protein targets of SIRT1
may have been impacted. Nevertheless, we focused our
attention toward SIRT2. SIRT2 functions as the
predominant microtubule deacetylase in mature mouse
cortical neurons, and impairment in tubulin
acetylation/deacetylation activity has been associated
with neuropathological features [67, 68]. The
localization of SIRT2 along the microtubule network
and the previous observation that regulation of neuronal
morphology depends on the ability of microtubules to
mediate intracellular transport and control local
signaling events led us to the discovery of a significant
reduction in SIRT2 protein expression in response to
RSV supplementation. Unexpectedly, a decrease in the
acetylated/total α-tubulin ratio through induction in αtubulin levels was observed, which suggested to us that
other tubulin deacetylases such as HDAC6 [69] were
refractory to RSV treatment. SIRT1 protein contains no
significant tubulin deacetylase activity (see Fig. 3C in
[56]). Limited studies in mice using genetic and
pharmacological approaches to disrupt SIRT2
expression and/or activity have generated divergent
outcome [70, 71]. Genetic knockout of SIRT2 in a
Huntington’s disease mouse model showed no
improvement in tubulin acetylation and the progression
of neurological pathologies [70], whereas treatment
with a SIRT2 inhibitor for up to 14 weeks confers
neuroprotection against Huntington’s related toxicity
[71]. In our study, the benefits of treating HFS-fed
monkeys with RSV for 2 years have been achieved
through partial depletion of SIRT2 protein levels and
improved neuroinflammation even though the identity
of the molecular targets of RSV remain unknown.

activation of NF-κB target genes were found to be
downregulated in the HFS+R group as compared to
HFS. It is interesting that chronic in vivo NFATdependent transcription leads to pathological formation
of neurofibrillary tangles in a mouse model of
Alzheimer’s disease, which can be attenuated by
polyphenols [72]. Moreover, RSV supplementation
prevents pathological cardiac hypertrophy by inhibiting
the transcription factor NFAT [73]. It remains to be
established whether NFAT activation occurs in cerebral
cortex of HFS-fed monkeys and returns to basal steady
state levels following diet supplementation with RSV.
Protection against progressive apoptotic cell death is a
desirable feature when considering the impact of longterm dietary stress. The increase in inflammation and
vascular dysfunction that results from obesity and
metabolic disorders led us to examine the expression of
apoptosis markers in monkey cerebral cortex. As
expected, a clear effect on BCL2 levels and amount of
active caspase 3 was observed in the HFS+R group as
compared to HFS, thus providing evidence of the antiapoptotic role of RSV against HFS-induced apoptosis.
Though there was less active caspase 3 in cerebral
cortex of the HFS group as compared to SD, BCL2 was
expressed at similar levels between the two groups,
indicating that the 2-year regimen with HFS may not
have been sufficient to promote overt neuroinflammation
and
apoptosis-related
events.
Alternatively, the indicated difference in active caspase
3 levels between the SD and HFS groups may not be
conclusive due to low SD sample size. ALDH2
expression was significantly reduced by HFS, but
normalized with RSV supplementation in parallel with
the increase in BCL2 levels, and this can explain the
compensatory changes to defend the brain against dietinduced oxidative damage leading to neuronal
apoptosis.
When combined with the observation that a 6-month
diet supplementation with RSV improves memory in
overweight older individuals [20], it appears likely that
attenuation of diet-induced neuroinflammation by brain
resident cells, e.g., activated microglia and astrocytes,
and perivascular macrophages may provide some of the
cognitive benefits of RSV. A 52-week administration of
1000 mg RSV twice daily in individuals with
Alzheimer’s disease has been found to be well tolerated
and resulted in changes in the trajectory of some
biomarkers compared to placebo [74].

The microarray experiment has identified a number of
genes that were impacted by RSV supplementation such
as voltage-gated potassium channel modulatory
subunits, the glutamate receptor and axonal spectrin.
Additionally, gene sets related to oxidative stress and
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Altogether the present work outlines the preclinical
efficacy of RSV supplementation in the prevention or
delay of cerebral vascular dysfunction induced by
dietary stress in rhesus monkeys, a highly relevant
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Tissue sample collection, brain sectioning and
immunofluorescence. At the end of the two-year dietary
treatment period, monkeys were anesthetized with
ketamine (7-10 mg/kg, IM). Following collection of
blood and cerebrospinal fluid (CSF), animals were
euthanized by an overdose of pentobarbital (50 mg/kg)
and perfused with cold lactated Ringer’s solution. Brain
and various other organs and tissues were harvested
immediately and either frozen at -80°C or fixed for
further analyses. All experimental procedures were
approved by the Animal Care and Use Committee of the
NIA Intramural Program. The final protocol number for
this project was #379-LEG-2010.

model of human health and disease. These findings add
to an expending literature investigating the benefits of
RSV in combatting various ailments [5].

METHODS
Animals and diets. Twenty-four adult (7-13 year old)
male rhesus monkeys (Macaca mulatta) were housed at
the NIH Animal Center. Animals were housed
individually in standard nonhuman primate caging, in a
temperature-regulated room (25 ± 1°C), humidity at 60
± 20%, on a 12h light/12h dark cycle (lights on from
6:00 to 18:00) with ad libitum access to drinking water.
All monkeys had extensive visual, auditory, and
olfactory but limited tactile contact with monkeys
housed in the same room. Monkeys were monitored
minimally 3 times daily by trained animal-care staff. All
procedures and animal care were conducted in
accordance with the National Institutes of Health (NIH)
Guide for the Care and Use of Laboratory Animals in an
AALAC-accredited facility.

Brains were cut into 8 x 1-cm thick coronal blocks
using a brain matrix. Each block was then cut sagittally
along the midline. The entire left side of the brain was
placed in 4% paraformaldehyde. Twenty-four to fortyeight hours after placement in paraformaldehyde, left
hemispheres were cryoprotected in 20% sucrose
solution for one week, then frozen in Cryo-Gel
(Electron Microscopy Sciences, Hatfield, PA, USA) for
sectioning. Coronal sections of 70 µm were cut through
the cortex blocks and stored free-floating in
cryopreservative solution (25% glycerol, 25% ethylene
glycol, 25% 0.2 M phosphate buffer, 25% water) at
−20°C. After washing, sections were treated with
Proteinase K solution for antigen retrieval and were
then treated with 1% of sodium-borohydride solution.
Brain sections were blocked in 5% BSA/TBS
(supplemented with 0.5% Triton X-100, 0.3 M glycine
and 1% fish gelatin) and then immunostained with
mouse anti-CD31 (Abcam, Cambridge, MA, USA) and
rabbit anti-Iba1 (Wako, Richmond, VA, USA)
antibodies at 4°C. After extensive washing, brain
sections were labeled with donkey anti-mouse IgG,
Alexa Fluor 488 and donkey anti-rabbit IgG, Alexa
Fluor 568 both from Life Technologies (Grand Island,
NY, USA), and then counterstained with 4',6diamidino-2-phenylindole. The mounted slides were
imaged by both fluorescence microscopy and on a Leica
confocal microscope using 20x and 40x objectives.

During baseline assessment, all monkeys were
maintained on standard NIH monkey chow (Purina
Mills). After baseline assessment, monkeys were quasirandomized to one of three dietary regimens such that
average age and bodyweight did not differ significantly
between groups: control diet group fed a healthy
standard diet (SD) with 13% kcal in fat and less than
5% sucrose by weight, high fat and sugar diet (HFS)
group fed with 42% kcal in fat and 27% sucrose by
weight (Harlan, Teklad, Indianapolis, IN, USA), and
HFS + RSV (HFS+R) group fed with the same HFS diet
plus a flavored primate treat (BioServ, Flemington, NJ,
USA) containing 40 mg RSV (DSM Nutritional
Products, Parsippany, NJ, USA) twice daily for one
year. For the second year of the study, the RSV dose
was increased to 240 mg twice a day to raise plasma
RSV levels at 27.7 ± 8.6 ng/ml (29). No adverse effects
to the RSV were evident. Monkeys in non-RSV groups
received placebo treats. The RSV dose (240 mg) was
derived from the protective dose reported in mice (22
mg/kg) [75] and adjusted by allometric scaling to an
average monkey body weight of 12.1 kg.

Capillary density in the cortex was quantified as the
length of blood vessels <10 μm in diameter per volume
of tissue using ImageJ software (NIH, Bethesda, MD,
USA). The total length of capillaries was divided by the
cortex area to obtain capillary density (length per area
of tissue). Immunofluorescence labeling for Iba1 was
used to identify microglia in the brain. The relative
number of Iba1-positive microglia per region of interest
in the cortex was calculated. The areas were analyzed
using the area measurement tool of the MetaMorph
software (version 7.7.9.0). In each animal, four
randomly selected fields from the cortex were analyzed

All groups received 2 meals per day in allotments that
represent ad libitum feeding. The HFS diet was
formulated to cause weight gain and symptoms of
metabolic syndrome, such as increased abdominal
circumference, higher serum insulin levels after an
intravenous glucose challenge, higher LDL-cholesterol
but lower HDL-cholesterol levels compared to baseline
levels, as well as lower insulin sensitivity after 24
months on a HFS diet [30, 31].
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in six nonadjacent sections for both staining. The
experimenter was blinded to the groups and animal
treatments throughout the analysis.

part of DIANE 6.0 and are available at
http://www.grc.nia.nih.gov/branches/rrb/dna/diane_soft
ware.pdf.

RNA extraction, cDNA synthesis, and quantitative
PCR. Total RNA was extracted from frozen monkey
temporal neocortex and purified using RNeasy Mini Kit
(Qiagen, Valencia, CA, USA). A total of 0.5-1 μg total
RNA was converted into first-strand cDNA using the
High-Capacity cDNA reverse transcription kit with
random hexamers, according to the manufacturer’s
instructions (Applied Biosystems, Foster City, CA,
USA). SYBR Green PCR Master Mix (Applied
Biosystems) was used for quantitative PCR reactions,
and samples were analyzed on the 7500 Real-Time PCR
System (Applied Biosystems). Oligonucleotide
sequences were as follows:
GRIN2B (XM_001088140.2), 5’-CCCAGATCCT
CGATTTCATT-3’ and 5’- GCCAAACTGGAAGAA
CATGG-3’;
SPTBN1 (NM_001266968.1), 5’- CCTCTGATCGCA
AAGCCAAGAC-3’ and 5’- CCACTCGTGTTTCCGA
TTGAG-3’;
KCNB1 (NM_001265653.1), 5’-ACCGAATCCAACA
AGAGCGT-3’
and
5’-TGCAAGCTTAAGGAT
GCGGA-3’;
glyceraldehyde phosphate dehydrogenase (GAPDH,
NM_001195426.1), 5’-TGAAGCAGGCGTCGGAGG
G-3’ and 5’-CGAAGGTGGAAGAGTGGGTG-3’.
Rhesus monkey PCR primer pairs were purchased from
Integrated DNA Technologies, Inc. (Coralville, IA,
USA). Fidelity of the PCR reactions was determined by
melting temperature analysis. All samples were run in
triplicate for each gene. The relative gene expression
was calculated using the ∆∆CT method normalized to
the housekeeping gene GAPDH, whose expression
remained constant in all experimental conditions.

Protein extraction, gel electrophoresis and Western
blotting. Frozen brain cortical tissues were
homogenized in ice-cold lysis buffer [31], and clarified
lysates were processed for SDS-polyacrylamide gel
electrophoresis under reducing conditions with proteins
transferred to nitrocellulose membranes. The
membranes were routinely stained with the Ponceau S
dye (Sigma-Aldrich, St-Louis, MO, USA) for the rapid
and reversible detection of protein bands. Protein
expression was detected using specific primary
antibodies. Antibodies raised against Bcl2, cleaved
caspase 3, FOXO3a, pVHL, acetyl-α-tubulin and
phospho-p65Rel (Ser 536) were purchased from Cell
Signaling Technology. (Danvers, MA, USA); NF-κB
from Epitomics (Burlingame, CA, USA); eNOS from
BD Biosciences (Franklin Lakes, NJ, USA); VEGF,
ALDH2, SIRT2, β-actin, GAPDH and α-tubulin from
Abcam; and HIF-1α from Cayman Chemicals (Ann
Arbor, MI, USA). All antibodies were detected with
horseradish peroxidase-conjugated secondary antibodies
(Santa Cruz Biotechnology, Dallas, TX, USA) and
visualized by enhanced chemiluminescence (GE
Healthcare, Piscataway, NJ, USA). Quantitation of the
protein bands was performed by volume densitometry
using ImageJ software.
Determination of dimeric and monomeric forms of
eNOS. eNOS dimeric and monomeric species were
separated, using low-temperature SDS–PAGE under
reducing conditions followed by Western blot analysis,
as described previously [77]. In brief, brain cortical
samples were not heated and the temperature of the gel
was maintained at 4°C during electrophoresis, which
enabled the detection of the dimeric and monomeric
forms of eNOS protein by immunoblotting.

cDNA microarray analysis. RNA was isolated from
rhesus monkey temporal neocortex at 24-months of
dietary intervention using Trizol reagent (Invitrogen,
Carlsbad, CA, USA) and further purified using RNeasy
mini columns (Qiagen). RNA was processed, labeled
and hybridized to Illumina HumanHT-12 V4.0
expression beadchip using standard Illumina protocols.
Raw data were subjected to Z normalization; individual
genes with Z ratio > 1.5 in both directions, P value <
0.05, and false discovery rate > 0.3 were considered
significantly changed. The number of samples for each
group was: SD =4, HFS =10, and HFS+R =10. Our
expression data was tested for gene set enrichment
using the parametric analysis of gene set enrichment
(PAGE) method [76]. For each Z (pathway), a P value
was also computed in JMP 6.0 to test for the
significance of the Z score obtained. These tools are
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Hydrogen sulfide measurement. Hydrogen sulfide
production was determined in protein lysates from
cerebral cortex following the method described by Hine
et al. [78]. In brief, brain tissues were homogenized in
passive lysis buffer (Promega, Madison, WI, USA)
followed by several rounds of flash freezing/thawing.
After normalization for protein content with the
bicinchoninic acid assay (Thermo Scientific Pierce,
Rockford, IL, USA), 125 mg of lysates was added to a
final reaction in 96-well format containing 10 mM
cysteine and 1 mM pyridoxal 5’-phosphate. Pieces of
lead acetate paper (15x10 cm) were made by soaking
VWR® grade 703 blotting paper (VWR International,
Radnor, PA, USA) in 20 mM lead acetate (SigmaAldrich) and then vacuum drying, followed by their
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positioning over the 96-well dish and incubation for 18
h at 37°C until lead sulfide was detected but not
saturated. Quantification was performed by volume
densitometry using ImageJ software.
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Supplemental Figure 1. Immunoblots used for quantitative analysis. Solubilized cerebral cortex extracts
from SD‐(n=4), HFS‐ (n=10) and HFS+R‐fed animals (n=10) were resolved by SDS‐PAGE under reducing conditions,
electrotransferred onto nitrocellulose membranes and subjected to immunoblotting using the indicated primary
antibodies. Probing membranes with GADPH and β‐actin demonstrated equal loading in each lane. Bands of
interest were quantitated by densitometry and normalized to Ponceau S staining of the membranes.
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